Markowski Investments’s PDS Biotechnology PDSB Stock Holding History

Markowski Investments’s Portfolio PDSB Stock Details PDSB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$441	Buy	+500	New	+$531	﹤0.01%	595

Other funds holding PDSB

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

MCM

Militia Capital Management Austin, Texas $3.37B AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Markowski Investments's PDSB Position: Q2 2026 in Review

Markowski Investments opened a new position in PDS Biotechnology (PDSB) in Q2 2026: 500 shares worth $441. The stake represents ﹤0.01% of the portfolio and ranks #595 among its holdings.

35 funds tracked by Wall St. Rank hold PDSB as of Q2 2026.

Markowski Investments held 500 shares of PDS Biotechnology worth $441 as of Q2 2026.
PDS Biotechnology was a new Markowski Investments position in Q2 2026.
PDS Biotechnology made up ﹤0.01% of Markowski Investments's portfolio in Q2 2026, its #595 holding.
35 funds tracked by Wall St. Rank held PDS Biotechnology as of Q2 2026.

Based on Markowski Investments's 13F filing for Q2 2026, filed 13 Aug 2026.